Tremeau Presentation at Advances in Pain Conference Highlights The History of Rofecoxib

Tremeau Founder & CEO Bradford C. Sippy presented at the Advances in Pain Conference, sponsored by the New York Academy of Science, in NYC on May 4, 2022. The presentation provides an analysis of what went wrong with VIOXX and a rationale for the re-introduction of rofecoxib as a non-opioid pain treatment option.